IntegenX and Promega said today that IntegenX's forthcoming RapidHit 200 human identification system will include Promega's nucleic acid purification and short tandem repeat amplification reagents under a reagent supply agreement between the companies.

Get the full story with GenomeWeb Premium

Only $95 for the first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.